Medication info
AM-Sartan Tablet 40/10 mg (Telmisartan, Amlodipine Besilate)

AM-Sartan Tablet 40/10 mg (Telmisartan, Amlodipine Besilate)

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Kolon Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double-coated tablet in white and light blue
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201701545 · Approved 2017.03.31 · Insurance code 670304110

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
Child dose
Pediatric patients 18 years of age or younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Kolon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure, which places a burden on the cardiovascular system. When blood pressure control is insufficient with either telmisartan or amlodipine monotherapy, this medication is used effectively to lower and manage blood pressure. This helps to reduce the risk of heart disease and stroke and improves overall vascular health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.

Child dose

Pediatric patients 18 years of age or younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, thus it should not be taken by pregnant women or those who may become pregnant. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This medication should be avoided or used with caution in patients with certain conditions. For example, those allergic to any components of this medication, patients with biliary obstruction, severe liver disease, severe hypotension, or serious heart conditions should not take it. Additionally, caution is needed for patients with diabetes or severe kidney disease, as it may pose risks when combined with certain other medications. Patients with impaired liver, heart, or kidney function should use this medication more cautiously. In patients with liver impairment, metabolism of the medication may be slowed, potentially requiring dosage adjustments. Caution is also needed in cases of heart failure or valvular heart disease. Side effects such as dizziness and peripheral edema are common, and serious adverse reactions such as fainting have been reported rarely. If side effects occur, immediate consultation with healthcare professionals is necessary. Symptoms of hypotension, such as excessively low blood pressure, may occur; therefore, especially in patients taking diuretics or those who may be dehydrated, the state should be carefully checked before taking the medication, following healthcare professionals' directives. There is a risk of elevated potassium levels in the blood, so when this medication is taken with other drugs that may raise potassium, monitoring through blood tests is necessary. Patients with reduced kidney function should also receive regular blood tests to check kidney function and electrolyte status. This medication can increase the risk of side effects when taken with other antihypertensive drugs, so be sure to inform healthcare providers when taking it with other medications. In particular, avoid taking it with grapefruit juice, as it can excessively enhance the medication's effect. Drowsiness or dizziness may occur while taking this medication, and caution is advised when driving or operating hazardous machinery. Safety and efficacy have not been established in children, so it is not recommended for use in this population. Elderly patients may be more sensitive to the effects of the medication, so caution is necessary when prescribing it, and dosage adjustments may be required. In cases of overdose, severe hypotension, dizziness, and cardiac issues may occur; therefore, avoid exceeding the prescribed dosage, and visit a medical facility immediately if any adverse symptoms appear. This medication should be kept out of reach of children, and it is recommended not to transfer to another container, opening the packaging just before consumption.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 111 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • dysgeusia
  • tremors
  • extrapyramidal disorders
  • muscle hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphic erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • lumbar pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • pollakiuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light, with a safe storage temperature between 1°C and 30°C at room temperature. Therefore, it is important to avoid direct sunlight and not to store it in excessively hot or cold places.

Appearance and packaging

Appearance

Biconvex oval double-coated tablet in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.